KRT13 is upregulated in pancreatic cancer stem-like cells and associated with radioresistance

Abstract Pancreatic cancer is one of the most aggressive cancers and the seventh leading cause of cancer-associated death in the world. Radiation is performed as an adjuvant therapy as well as anti-cancer drugs. Because cancer stem-like cells (CSCs) are considered to be radioresistant and cause recurrence and metastasis, understanding their properties is required for the development of novel therapeutic strategies. To investigate the CSC properties of pancreatic cancer cells, we used a pancreatic CSC model, degron (++) cells, which have low proteasome activity. Degron (++) cells displayed radioresistance in comparison with control cells. Using Ribonucleic acid (RNA) sequencing, we successfully identified KRT13 as a candidate gene responsible for radioresistance. Knockdown of KRT13 sensitized the degron (++) cells to radiation. Furthermore, a database search revealed that KRT13 is upregulated in pancreatic cancer cell lines and that high expression of KRT13 is associated with poorer prognosis. These results indicate that a combination therapy of KRT13 knockdown and radiation could hold therapeutic promise in pancreatic cancer.

[1]  Ji-Rong Wen,et al.  Upregulation of the transmembrane protease serine 3 mRNA level in radioresistant colorectal cancer tissues. , 2022, Biomarkers in medicine.

[2]  Jayoung Kim,et al.  KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway , 2022, Breast cancer research : BCR.

[3]  Shogo Kobayashi,et al.  Functional assessment of miR-1291 in colon cancer cells , 2022, International journal of oncology.

[4]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[5]  T. Okamoto,et al.  Enhanced KRT13 gene expression bestows radiation resistance in squamous cell carcinoma cells , 2021, In Vitro Cellular & Developmental Biology - Animal.

[6]  Abdul Quaiyoom Khan,et al.  Recent developments in unraveling signaling mechanisms underlying drug resistance due to cancer stem-like cells. , 2020, Current opinion in pharmacology.

[7]  Wei Zhang,et al.  KRT6A Promotes EMT and Cancer Stem Cell Transformation in Lung Adenocarcinoma , 2020, Technology in cancer research & treatment.

[8]  Y. Doki,et al.  miR-4711-5p regulates cancer stemness and cell cycle progression via KLF5, MDM2 and TFDP1 in colon cancer cells , 2020, British Journal of Cancer.

[9]  Wen Peng,et al.  Targeting cancer stem cell pathways for cancer therapy , 2020, Signal Transduction and Targeted Therapy.

[10]  P. Antosik,et al.  Markers of pancreatic cancer stem cells and their clinical and therapeutic implications , 2019, Molecular Biology Reports.

[11]  K. Goodman,et al.  Radiation therapy for pancreatic adenocarcinoma, a treatment option that must be considered in the management of a devastating malignancy , 2019, Radiation oncology.

[12]  Ssang-Goo Cho,et al.  Opposing Regulation of Cancer Properties via KRT19-Mediated Differential Modulation of Wnt/β-Catenin/Notch Signaling in Breast and Colon Cancers , 2019, Cancers.

[13]  Subbroto Kumar Saha,et al.  Cytokeratin 19 (KRT19) has a Role in the Reprogramming of Cancer Stem Cell-Like Cells to Less Aggressive and More Drug-Sensitive Cells , 2018, International journal of molecular sciences.

[14]  Y. Doki,et al.  A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in KRAS-Mutant Colon Cancer Cells , 2018, Molecular Cancer Therapeutics.

[15]  Suiqun Guo,et al.  TGF‐β1‐induced CK17 enhances cancer stem cell‐like properties rather than EMT in promoting cervical cancer metastasis via the ERK1/2‐MZF1 signaling pathway , 2017, The FEBS journal.

[16]  R. Orlowski,et al.  Proteasome inhibitors in cancer therapy , 2017, Nature Reviews Clinical Oncology.

[17]  Sungyong You,et al.  Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells , 2016, Oncotarget.

[18]  C. Galet,et al.  Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone , 2016, PloS one.

[19]  Jordan Anaya,et al.  OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs , 2016, PeerJ Comput. Sci..

[20]  Y. Doki,et al.  Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity , 2016, Clinical Cancer Research.

[21]  H. Ishii,et al.  Cancer stem cells: The potential of carbon ion beam radiation and new radiosensitizers (Review). , 2015, Oncology reports.

[22]  K. Shroyer,et al.  Keratin-17 Promotes p27KIP1 Nuclear Export and Degradation and Offers Potential Prognostic Utility. , 2015, Cancer research.

[23]  Teresa L. Mastracci,et al.  Krt19(+)/Lgr5(-) Cells Are Radioresistant Cancer-Initiating Stem Cells in the Colon and Intestine. , 2015, Cell stem cell.

[24]  E. Hatano,et al.  Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma , 2015, Clinical Cancer Research.

[25]  C. Willett,et al.  Adjuvant radiation therapy for pancreatic cancer: a review of the old and the new. , 2015, Journal of gastrointestinal oncology.

[26]  Y. Doki,et al.  Innovative Delivery of siRNA to Solid Tumors by Super Carbonate Apatite , 2015, PloS one.

[27]  Y. Doki,et al.  Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer , 2015, Molecular therapy. Nucleic acids.

[28]  M. Hatta,et al.  Epigenetic alterations of the keratin 13 gene in oral squamous cell carcinoma , 2014, BMC Cancer.

[29]  H. Ishii,et al.  Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity. , 2014, International journal of oncology.

[30]  H. Ishii,et al.  Visualization and characterization of cancer stem-like cells in cervical cancer. , 2014, International journal of oncology.

[31]  R. Sarkany,et al.  Upregulation of MMP12 and its activity by UVA1 in human skin: potential implications for photoaging. , 2014, The Journal of investigative dermatology.

[32]  Z. Weng,et al.  Keratin-6 driven ODC expression to hair follicle keratinocytes enhances stemness and tumorigenesis by negatively regulating Notch. , 2014, Biochemical and biophysical research communications.

[33]  P. Mischel,et al.  Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients , 2014, BMC Cancer.

[34]  Joe Y. Chang,et al.  Therapy-Resistant Cancer Stem Cells Have Differing Sensitivity to Photon versus Proton Beam Radiation , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[35]  F. Pajonk,et al.  Targeted elimination of breast cancer cells with low proteasome activity is sufficient for tumor regression , 2013, Breast Cancer Research and Treatment.

[36]  S. Arii,et al.  Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents. , 2012, Gastroenterology.

[37]  F. Pajonk,et al.  Radioresistance of prostate cancer cells with low proteasome activity , 2012, The Prostate.

[38]  Takanori Kobayashi,et al.  Loss of keratin 13 in oral carcinoma in situ: a comparative study of protein and gene expression levels using paraffin sections , 2012, Modern Pathology.

[39]  S. Dalal,et al.  Loss of keratins 8 and 18 leads to alterations in α6β4-integrin-mediated signalling and decreased neoplastic progression in an oral-tumour-derived cell line , 2011, Journal of Cell Science.

[40]  R. Okayasu,et al.  Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays. , 2011, Cancer research.

[41]  V. Karantza,et al.  Keratins in health and cancer: more than mere epithelial cell markers , 2011, Oncogene.

[42]  M. You,et al.  26S Proteasome Activity Is Down-Regulated in Lung Cancer Stem-Like Cells Propagated In Vitro , 2010, PloS one.

[43]  B. Christensen,et al.  Identification of Methylated Genes Associated with Aggressive Bladder Cancer , 2010, PloS one.

[44]  P. Drew,et al.  Proteomic identification of putative biomarkers of radiotherapy resistance: a possible role for the 26S proteasome? , 2009, Neoplasia.

[45]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[46]  J. Sayre,et al.  In vivo imaging, tracking, and targeting of cancer stem cells. , 2009, Journal of the National Cancer Institute.

[47]  R. Moll,et al.  The human keratins: biology and pathology , 2008, Histochemistry and Cell Biology.

[48]  L. David,et al.  Keratins 8, 10, 13, and 17 are useful markers in the diagnosis of human cervix carcinomas. , 2004, Human pathology.

[49]  T. Gress,et al.  A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. , 2000, Cancer research.

[50]  R. Derynck,et al.  Transforming growth factor-beta activation in irradiated murine mammary gland. , 1994, The Journal of clinical investigation.

[51]  M. Miettinen,et al.  Expression of keratin 13 in human epithelial neoplasms , 2005, Virchows Archiv A.